Prion propagation in vitro: Are we there yet?

International Journal of Medical Sciences

Volumn 5, Issue 6, 2008, Pages 347-353

  Ryou, Chongsuk ^a,b   Mays, Charles E ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NONE   (United States)

Author keywords

Cellular prion protein; Disease associated scrapie prion protein; In vitro conversion; In vitro prion amplification; Prion; Prion disease; Prion infectivity

Indexed keywords

PRION PROTEIN;

CELL ASSAY; IN VITRO STUDY; MICROSOME MEMBRANE; NEUROPATHOLOGY; NONHUMAN; PRION DISEASE; PROTEIN EXPRESSION; REVIEW; ULTRASOUND;

EID: 56449111087     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.5.347     Document Type: Review

References (42)

1. Prusiner SB. An introduction to prion biology and diseases. In: Prusiner SB, ed. Prion Biology and Diseases, 2nd ed. S. B. Prusiner. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 2004: 1-87.
2. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-144.
3. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-13383.
4. Ryou C. Prions and prion diseases: Fundamentals and mechanistic details. J Microbiol Biotechnol 2007; 17:1059-1070.
5. Prusiner SB, Scott M, Foster D, Pan K-M, Groth D, Mirenda C, Torchia M, Yang S-L, Serban D, Carlson GA, Hoppe PC, Westaway D, DeArmond SJ. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990; 63:673-686.
6. Race RE, Fadness LH, Chesebro B. Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol 1987; 68:1391-1399.
7. Raeber AJ, Borchelt DR, Scott M, Prusiner SB. Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems. J Virol 1992; 66:6155-6163.
8. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471-474.
9. Caughey B, Kocisko DA, Raymond GJ, Lansbury PT. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol 1995; 2:807-817.
10. Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between heterologous forms of prion protein: Binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci USA 2000; 97:5836-5841.
11. Raymond GJ, Bossers A, Raymond LD, O'Rourke KI, McHolland LE, Bryant PK, Miller MW, Williams ES, Smits M, Caughey B. Evidence of a molecular barrier limiting susceptibility to humans, cattle and sheep to chronic wasting disease. EMBO J 2000; 19:4425-4430.
12. Sc) into contiguous membranes. EMBO J 2002; 21:1031-1040.
13. Callahan MA, Xiong L, Caughey B. Reversibility of scrapie-associated prion protein aggregation. J Biol Chem 2001; 276:28022-28028.
14. Caughey B, Raymond LD, Raymond GJ, Maxson L, Silveira J, Baron GS. Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J Virol 2003; 77:5499-5502.
15. Sc-dependent cell-free formation of protease-resistant prion protein. EMBO J 2001; 20:377-386.
16. Horiuchi M, Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J 1999; 18:3193-3203.
17. Maxson L, Wong C, Herrmann LM, Caughey B, Baron GS. A solid-phase assay for identification of modulators of prion protein interactions. Anal Biochem 2003; 323:54-64.
18. Kocisko DA, Baron GS, Rubenstein R, Chen J, Kuizon S, Caughey B. New inhibitors of scrapie-associated prion protein formation in a library of 2,000 drugs and natural products. J Virol 2003; 77:10288-10294.
19. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature 2005; 437:257-261.
20. Eiden M, Palm GJ, Hinrichs W, Matthey U, Zahn R, Groschup MH. Synergistic and strain-specific effects of bovine spongiform encephalopathy and scrapie prions in the cell-free conversion of recombinant prion protein. J Gen Virol 2006; 87:3753-61.
21. C. J Gen Virol 2000; 81:2565-71.
22. res as a model for conversion. J Gen Virol 2003; 84:1013-1020.
23. Hill AF, Antoniou M, Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 1999; 80:11-14.
24. Saborio GP, Soto C, Kascsak RJ, Levy E, Kascsak R, Harris DA, Frangione B. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem Biophys Res Commun 1999; 258:470-475.
25. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810-813.
26. Castilla J, Saa P, Morales R, Abid K, Maundrell K, Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006; 412:3-21.
27. Castilla J, Saa P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell 2005; 121:195-206.
28. Soto C, Anderes L., Suardi S, Cardone F, Castilla J, Frossard M, Peano S, Saa P, Limido L, Carbonatto M, Ironside J, Torres J, Pocchiari M, Tagliavini F. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 2005;579:638-642.
29. Lucassen R, Nishina K, Supattapone S. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochemistry 2003; 42:4127-4135.
30. Deleault N, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 2005; 280:26873-26879.
31. Orem NR, Geoghegan JC, Deleault NR, Kascsak R, Supattapone S. Copper (II) ions potently inhibit purified PrPres amplification. J Neurochem 2006; 96:1409-1415.
32. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104:9741-9746.
33. Geoghegan JC, Valdes PA, Orem NR, Deleault NR, Williamson RA, Harris BT, Supattapone S. Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem 2007; 282:36341-36353.
34. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, Priola SA, Caughey B. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 2007; 4:645-648.
35. Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, Onwubiko HA, Priola SA, Caughey B. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 2008; 5:211-212.
36. Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE. Pathway complexity of prion protein assembly into amyloid. J Biol Chem 2002; 277:21140-21148.
37. Sc. J Mol Biol 2005; 346:645-659.
38. Baskakov IV. Autocatalytic conversion of recombinant prion proteins displays a species barrier. J Biol Chem 2004; 279:7671-7677.
39. Breydo L, Bocharova OV, Baskakov IV. Semiautomated cell-free conversion of prion protein: Applications for high-throughput screening of potential antiprion drugs. Anal Biochem 2005; 339:165-173.
40. Legname G, Baskakov IV, Nguyen HB, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB. Synthetic mammalian prions. Science 2004; 305:673-676.
41. Legname G, Nguyen HO, Baskakov IV, Cohen FE, Dearmond SJ, Prusiner SB. Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci USA 2005; 102:2168-2173.
42. Westaway D, DeArmond SJ, Cayetano-Canlas J, Groth D, Foster D, Yang SL, Torchia M, Carlson GA, Prusiner SB. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 1994; 76:117-129.